Clinical Trial Update: HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 1 [NA]

View source ↗

Summary

A completed pilot clinical trial (HARP Pilot 1) at Yale evaluating polypharmacy in people with HIV and alcohol use disorder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• HIV Infection

Snippet

Sponsor: Yale University | Conditions: HIV, Alcohol Use | NA | Status: COMPLETED | Results posted: 2025-07-04